BioVie Statistics
Total Valuation
BioVie has a market cap or net worth of $7.54 million. The enterprise value is -$5.27 million.
| Market Cap | 7.54M |
| Enterprise Value | -5.27M |
Important Dates
The next estimated earnings date is Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioVie has 7.54 million shares outstanding. The number of shares has increased by 391.54% in one year.
| Current Share Class | 7.54M |
| Shares Outstanding | 7.54M |
| Shares Change (YoY) | +391.54% |
| Shares Change (QoQ) | -4.76% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 14.17% |
| Float | 7.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.97, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.97 |
| Quick Ratio | 9.02 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,088.49 |
Financial Efficiency
Return on equity (ROE) is -106.43% and return on invested capital (ROIC) is -67.59%.
| Return on Equity (ROE) | -106.43% |
| Return on Assets (ROA) | -61.04% |
| Return on Invested Capital (ROIC) | -67.59% |
| Return on Capital Employed (ROCE) | -130.18% |
| Weighted Average Cost of Capital (WACC) | 7.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.54M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.44% in the last 52 weeks. The beta is 0.67, so BioVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -74.44% |
| 50-Day Moving Average | 1.70 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 37.20 |
| Average Volume (20 Days) | 752,297 |
Short Selling Information
The latest short interest is 655,264, so 8.69% of the outstanding shares have been sold short.
| Short Interest | 655,264 |
| Short Previous Month | 449,023 |
| Short % of Shares Out | 8.69% |
| Short % of Float | 8.74% |
| Short Ratio (days to cover) | 2.81 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -20.60M |
| Pretax Income | -19.92M |
| Net Income | -19.96M |
| EBITDA | -20.37M |
| EBIT | -20.60M |
| Earnings Per Share (EPS) | -$3.49 |
Balance Sheet
The company has $13.10 million in cash and $295,717 in debt, with a net cash position of $12.80 million or $1.70 per share.
| Cash & Cash Equivalents | 13.10M |
| Total Debt | 295,717 |
| Net Cash | 12.80M |
| Net Cash Per Share | $1.70 |
| Equity (Book Value) | 15.61M |
| Book Value Per Share | 2.07 |
| Working Capital | 15.19M |
Cash Flow
| Operating Cash Flow | -20.51M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 229,377 |
| Net Borrowing | 2.90M |
| Free Cash Flow | -20.51M |
| FCF Per Share | -$2.72 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BioVie does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -391.54% |
| Shareholder Yield | -391.54% |
| Earnings Yield | -264.84% |
| FCF Yield | -272.15% |
Analyst Forecast
The average price target for BioVie is $5.26, which is 426.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.26 |
| Price Target Difference | 426.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 7, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |